NASDAQ Congratulates Portfolio Insider: Among The Fastest Growing Fintechs In The U.S.
19.8.2021 13:00:00 EEST | Business Wire | Press release
NASDAQ congratulated Portfolio Insider on the iconic MarketSite tower’s LED electronic video display in Times Square as among the fastest-growing Fintech companies in America. The hyper growing financial analytics company has democratized access to valuable financial data, delivering nearly anyone the same level of investing insights enjoyed by institutions and hedge funds.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210819005136/en/
On Thursday, August 11, 2021, NASDAQ's Times Square New York City LED screen displayed a congratulatory message to artificial intelligence-powered financial insights platform Portfolio Insider. (Photo: Business Wire)
Record Growth This Year.
The pandemic spurred a flood of new retail investors into the stock market, making up nearly 34% of U.S. stocks according to the Federal Reserve. It created an unprecedented level of demand for financial insights. Portfolio Insider grew revenue by over 300% in only the first half of this year, hiring over 70 new staff to build out Blockchain Analytics and machine learning models for financial data. Senior analyst Christopher Koo said, “Accurate data underpins sound decision-making, and we see virtually no limit to the amount of demand for more powerful algorithms and tools to level the playing field.”
AI Technology To “Make Investing Human.”
Computer programmers used to strenuously translate their intentions into the language of machines. Now, leveraging the world's largest autoregressive language model, those machines are conversant with the language of humans. Portfolio Insider believes they can “make investing more human” by developing on one of the most powerful neural networks ever created. By applying artificial intelligence to areas like unstructured data in financial reports, heuristic search, and a human intuitive SQL-like query for fundamental financial data, it enables anyone to build their own Bloomberg terminal for free. Portfolio Insider Chief AI Officer Noah Mitsuhashi said, “Technology has reached the evolutionary speed where intense tasks just years or months ago are now trivial and basic. Technology is growing exponentially, shaping a future where technology becomes virtually indistinguishable from magic. We contribute to human progress by enabling a fair playing field for retail investors.”
About The Company.
Portfolio Insider is a fintech analytics company powering the open finance revolution. They contribute to the Fintech landscape by democratizing access to the world's most valuable financial data and bring transparency to capital markets. Reaching millions of people each month, they provide on-chain market intelligence and real-time data services for institutional and retail stakeholders.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210819005136/en/
Contact information
Noah Mitsuhashi
323-483-4014
content@portfolioinsider.com
PortfolioInsider.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 23:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired. The transaction was unanimously approved by both the Vertex and Crinetics Boards of Directors and is anticipated to close in the third quarter of 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706876183/en/ Crinetics’ marketed medicine, PALSONIFY® (paltusotine), received approval from the U.S. Food and Drug Administration (FDA) in September 2025. PALSONIFY was recently approved by the European Medicines Agency (EMA) a
Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 21:30:00 EEST | Press release
The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stage name of Simone Privitera, an Italian multi-platinum DJ and producer who integrates artificial intelligence tools into a musical practice rooted in the contemporary electronic scene. With a career that has seen him collaborate wit
Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 20266.7.2026 16:00:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 30, 2026. The company will host a conference call and webcast on that date to discuss the second quarter 2026 results and the second half 2026 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706560476/en/ Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 2026 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasda
Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe6.7.2026 16:00:00 EEST | Press release
Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world’s most widely used cancer immunotherapies to widen patient access across Europe. Nivolumab helped usher in the era of immuno-oncology, transforming the outlook for patients with cancers such as melanoma and lung cancer. As the originator approaches loss of exclusivity in Europe, this partnership aims to put a high-quality, EU-GMP-manufactured nivolumab biosimilar within reach of more patients, reducing healthcare burden. In 2025, Nivolumab recorded sales of approximately USD4.1 billion (Source: IQVIA/IMS) Europe — underscoring the scale of the opportunity. Under the agreement, Orion will hold the exclusive rights to register, market, distribute and sell the nivolumab biosimilar across Europe. Shilpa Biologicals will lead product developm
No-Loss Trading Platform UpsideOnly Surpasses 100,000 Users Within Weeks of Launch6.7.2026 15:48:00 EEST | Press release
Perpetuals.com Ltd (Nasdaq: PDC), today announced that UpsideOnly, its risk-free trading and market prediction platform, has seen a surge in new user sign-ups, surpassing the important milestone of 100,000 traders within weeks of its launch on May 19. UpsideOnly lets users make predictions about where global equity, commodity, forex, and crypto markets are heading without ever placing a real trade themselves. Perpetuals uses its own capital to trade on the strongest signals identified by its proprietary AI. If those trades win, Perpetuals shares the profits with the users who helped generate the signal. If the trade doesn’t make money, users lose nothing. Reaching 100,000 users so quickly after launching is a reflection of the enormous demand for a platform that flips the traditional retail trading model on its head, with early platform data showing strong engagement across asset classes, geographies and user activity: Users from more than 180 different countries $38.4 billion in cumul
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom